Association between Obsessive-Compulsive Symptoms and Long-Term Cardiac Outcomes in Patients with Acute Coronary Syndrome: Effects of Depression Comorbidity and Treatment
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
This study investigated the association between OCS and the long-term prognosis of ACS in tandem with depression comorbidity and treatment. Methods A cross-sectional baseline study and a nested 24-week double-blind escitalopram-placebo controlled trial were carried out between May 2007 and March 2013, and then a 5–12-year follow-up for major adverse cardiac events (MACE) was conducted. A total of 1,152 patients with ACS were stratified by baseline depression comorbidity and treatment allocation into four groups: no depression (706 patients), depression and taking escitalopram (149 patients), depression and taking a placebo (151 patients), and depression and receiving medical care as usual (CAU; 146 patients). OCS were evaluated using the Symptom Checklist-90-Revised Obsessive-Compulsive symptom domain. During the follow-up, Kaplan-Meier event rates for MACE outcomes were calculated, and hazard ratios were estimated using Cox regression models after adjusting for a range of covariates. Results A higher OCS score at baseline was associated with a worse ACS prognosis after adjusting for relevant covariates and across MACE outcomes. This association varied according to the depression comorbidity. The association was significant in patients without depression and depressive patients receiving placebos and CAU, but not in depressive patients on escitalopram. Conclusion Evaluating OCS and depression is recommended during the early phase of ACS. Treatment for OCS may improve the longterm cardiac outcomes of patients with ACS.
Abstract
This study investigated the association between OCS and the long-term prognosis of ACS in tandem with depression comorbidity and treatment. Methods A cross-sectional baseline study and a nested 24-week double-blind escitalopram-placebo controlled trial were carried out between May 2007 and March 2013, and then a 5–12-year follow-up for major adverse cardiac events (MACE) was conducted. A total of 1,152 patients with ACS were stratified by baseline depression comorbidity and treatment allocation into four groups: no depression (706 patients), depression and taking escitalopram (149 patients), depression and taking a placebo (151 patients), and depression and receiving medical care as usual (CAU; 146 patients). OCS were evaluated using the Symptom Checklist-90-Revised Obsessive-Compulsive symptom domain. During the follow-up, Kaplan-Meier event rates for MACE outcomes were calculated, and hazard ratios were estimated using Cox regression models after adjusting for a range of covariates. Results A higher OCS score at baseline was associated with a worse ACS prognosis after adjusting for relevant covariates and across MACE outcomes. This association varied according to the depression comorbidity. The association was significant in patients without depression and depressive patients receiving placebos and CAU, but not in depressive patients on escitalopram. Conclusion Evaluating OCS and depression is recommended during the early phase of ACS. Treatment for OCS may improve the longterm cardiac outcomes of patients with ACS.
참고문헌 (40)
- Johansson S, "Mortality and morbidity trends after the first year in survivors of acute myocardial infarction : a systematic review", BMC Cardiovasc Disord, 17, pp.53~ (2017)
- Kuper H, "Systematic review of prospective cohort studies of psychosocial factors in the etiology and prognosis of coronary heart disease", Semin Vasc Med, 2, pp.267~314 (2002)
- American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" (2013), American Psychiatric Association
- Bezgin CH, "Temperament and character profiles and psychiatric comorbidities in patients with coronary artery or valvular heart disease : relationship with cardiac disease severity", J Clin Med Res, 8, pp.202~209 (2016)
- Hamideh pour OJ, "Compare the obsessive-compulsive disorders between coronary heart disease and healthy subjects", J Nov Appi Sci, 3, pp.283~286 (2014)
- Parker G, "The impact of differing anxiety disorders on outcome following an acute coronary syndrome: time to start worrying?", Depress Anxiety, 23, pp.302~309 (2010)
- Parker G, "GAD is good? Generalized anxiety disorder predicts a superior five-year outcome following an acute coronary syndrome", Psychiatry Res, 188, pp.383~389 (2011)
- Ruscio AM, "The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication", Mol Psychiatry, 15, pp.53~63 (2010)
- Overbeek T, "Comorbidity of obsessive-compulsive disorder and depression : prevalence, symptom severity, and treatment effect", J Clin Psychiatry, 63, pp.1106~1112 (2002)
- Spies M, "The serotonin transporter in psychiatric disorders : insights from PET imaging", Lancet Psychiatry, 2, pp.743~755 (2015)
- Kim JM, "Escitalopram treatment for depressive disorder following acute coronary syndrome : a 24-week double-blind, placebo-controlled trial", J Clin Psychiatry, 76, pp.62~68 (2015)
- Kim JM, "Effect of escitalopram vs placebo treatment for depression on long-term cardiac outcomes in patients with acute coronary syndrome : a randomized clinical trial", JAMA, 320, pp.350~358 (2018)
- Lee KH, "Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol", J Am Coll Cardiol, 58, pp.1664~1671 (2011)
- Anderson JL, "2012 ACCF", AHA focused update incorporated into the ACCF, non-ST-elevation myocardial infarction : a report of the American College of Cardiology Foundation, pp.American Heart Association Task Force on Practice Guidelines, Circulation[DOI]
- Derogatis LR, "SCL-90-R: Administration, Scoring & Procedures Manual-II for the Revised Version and Other Instruments of the Psychopathology Rating Scale Series", Psychometric Research, ~ (1992)
- Follick MJ, "Quality of life post-myocardial infarction : effects of a transtelephonic coronary intervention system", Health Psychol, 7, pp.169~182 (1988)
- Allison TG, "Medical and economic costs of psychologic distress in patients with coronary artery disease", Mayo Clin Proc, 70, pp.734~742 (1995)
- Sheehan DV, "The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10", J Clin Psychiatry, 59(Suppl 20), pp.22~33 (1998)
- Jaffe AS, "Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients(ENRICHD)study", Am Heart J, 152, pp.126~135 (2006)
- Beck AT, "An inventory for measuring depression", Arch Gen Psychiatry, 4, pp.561~571 (1961)
- Killip T, 3rd, "Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients", Am J Cardiol, 20, pp.457~464 (1967)
- Núñez-Rodríguez MH, "Psychological factors in gastroesophageal reflux disease measured by scl-90-R questionnaire", Dig Dis Sci, 53, pp.3071~3075 (2008)
- Panteghini M, "Role and importance of biochemical markers in clinical cardiology", Eur Heart J, 25, pp.1187~1196 (2004)
- Atmaca M, "Low plasma adiponectin levels in obsessive-compulsive disorder", J Affect Disord, 117, pp.205~207 (2009)
- Ari M, "Serum adiponectin and resistin levels in patients with obsessive compulsive disorder", J Affect Disord, 136, pp.979~982 (2012)
- Paterniti S, "Sustained anxiety and 4-year progression of carotid atherosclerosis", Arterioscler Thromb Vasc Biol, 21, pp.136~141 (2001)
- Isomura K, "Metabolic and cardiovascular complications in obsessive-compulsive disorder : a total population, sibling comparison study with long-term follow-up", Biol Psychiatry, 84, pp.324~331 (2018)
- Pittig A, "Heart rate and heart rate variability in panic, social anxiety, obsessive-compulsive, and generalized anxiety disorders at baseline and in response to relaxation and hyperventilation", Int J Psychophysiol, 87, pp.19~27 (2013)
- Simon D, "Autonomic responses and neural-cardiac coupling during individually tailored symptom provocation in obsessive-compulsive disorder", J Anxiety Disord, 27, pp.635~644 (2013)
- Díaz-Román A, "Sleep in obsessivecompulsive disorder : a systematic review and meta-analysis", Sleep Med, 16, pp.1049~1055 (2015)
- Hezel DM, "A theoretical review of cognitive biases and deficits in obsessive-compulsive disorder", Biol Psychol, 121, pp.221~232 (2016)
- Cavedini P, "Decision-making heterogeneity in obsessive-compulsive disorder : ventromedial prefrontal cortex function predicts different treatment outcomes", Neuropsychologia, 40, pp.205~211 (2002)
- Moritz S, "Quality of life in obsessive-compulsive disorder before and after treatment", Compr Psychiatry, 46, pp.453~459 (2005)
- Bloch MH, "Meta-analysis of the dose-response relationship of SSRI in obsessivecompulsive disorder", Mol Psychiatry, 15, pp.850~855 (2010)
- Dawood T, "Examining endothelial function and platelet reactivity in patients with depression before and after SSRI therapy", Front Psychiatry, 7, pp.18~ (2016)
- Alvares GA, "Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications : a systematic review and meta-analysis", J Psychiatry Neurosci, 41, pp.89~104 (2016)
- Woody SR, "Reliability and validity of the Yale-Brown Obsessive-Compulsive Scale", Behav Res Ther, 33, pp.597~605 (1995)
- Goodman WK, "The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability", Arch Gen Psychiatry, 46, pp.1006~1011 (1989)
- Grabill K, "Assessment of obsessive-compulsive disorder : a review", J Anxiety Disord, 22, pp.1~17 (2008)
- Schmitz N, "Diagnosing mental disorders in primary care : the General Health Questionnaire(GHQ)and the Symptom Check List(SCL-90-R)as screening instruments", Soc Psychiatry Psychiatr Epidemiol, 34, pp.360~366 (1999)